| __timestamp | Apellis Pharmaceuticals, Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 7459000 |
| Thursday, January 1, 2015 | 13730311 | 11831000 |
| Friday, January 1, 2016 | 22978599 | 25705000 |
| Sunday, January 1, 2017 | 40303878 | 46181000 |
| Monday, January 1, 2018 | 105285576 | 59497000 |
| Tuesday, January 1, 2019 | 220968770 | 65003000 |
| Wednesday, January 1, 2020 | 299921000 | 74506000 |
| Friday, January 1, 2021 | 420869000 | 126006000 |
| Saturday, January 1, 2022 | 387236000 | 126215000 |
| Sunday, January 1, 2023 | 354387000 | 120161000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Apellis Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Apellis has consistently outspent Protagonist, with R&D expenses peaking in 2021 at approximately 420% higher than their 2014 levels. Protagonist, while spending less, has shown a steady increase, with their R&D expenses growing by over 160% during the same period. This trend highlights Apellis's aggressive strategy in prioritizing innovation, while Protagonist adopts a more measured approach. As the pharmaceutical landscape evolves, these investments could be pivotal in determining which company leads in groundbreaking treatments and therapies.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
R&D Insights: How GSK plc and Protagonist Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and MorphoSys AG
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for Protagonist Therapeutics, Inc. and Travere Therapeutics, Inc.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending